Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabella Zwiener

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Statistics in Medicine|August 4, 2012
Sample size planning for survival prediction with focus on high-dimensional dataHeiko Götte, Isabella Zwiener
Plos One|January 14, 2014
Transforming RNA-Seq data to improve the performance of prognostic gene signaturesIsabella Zwiener, Barbara Frisch, Harald Binder
Deutsches Arzteblatt International|April 9, 2011
Survival analysis: part 15 of a series on evaluation of scientific publicationsIsabella Zwiener, Maria Blettner, Gerhard Hommel
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|August 24, 2010
Subconjunctival reflux and need for paracentesis after intravitreal injection of 0.1 ml bevacizumab: comparison between 27-gauge and 30-gauge needleKatrin Lorenz, Isabella Zwiener, Alireza Mirshahi
BMC Ophthalmology|December 24, 2013
Risk factors of a reduced response to ranibizumab treatment for neovascular age-related macular degeneration--evaluation in a clinical settingChristina Korb, Isabella Zwiener, Katrin Lorenz, et al.
Advances in Therapy|May 7, 2020
Pooled Safety and Tolerability Analysis of Empagliflozin in Patients with Type 2 Diabetes MellitusOna Kinduryte Schorling, Douglas Clark, Isabella Zwiener, et al.
Cardiovascular Diabetology|October 14, 2020
Empagliflozin reduced long-term HbA1c variability and cardiovascular death: insights from the EMPA-REG OUTCOME trialAntonio Ceriello, Anne Pernille Ofstad, Isabella Zwiener, et al.
Acta Ophthalmologica|June 30, 2010
Intravitreal ranibizumab treatment of retinal angiomatous proliferationChristina A Kramann, Kilian Schöpfer, Katrin Lorenz, et al.
Journal of the American College of Cardiology|March 20, 2019
Influence of Microvascular Disease on Cardiovascular Events in Type 2 DiabetesSubodh Verma, Christoph Wanner, Isabella Zwiener, et al.
European Journal of Radiology|July 18, 2016
Differences of airway dimensions between patients with and without bronchiolitis obliterans syndrome after lung transplantation-Computer-assisted quantification of computed tomographyFelix Doellinger, Oliver Weinheimer, Isabella Zwiener, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Statistics in Medicine|August 4, 2012
Sample size planning for survival prediction with focus on high-dimensional dataHeiko Götte, Isabella Zwiener
Plos One|January 14, 2014
Transforming RNA-Seq data to improve the performance of prognostic gene signaturesIsabella Zwiener, Barbara Frisch, Harald Binder
Deutsches Arzteblatt International|April 9, 2011
Survival analysis: part 15 of a series on evaluation of scientific publicationsIsabella Zwiener, Maria Blettner, Gerhard Hommel
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|August 24, 2010
Subconjunctival reflux and need for paracentesis after intravitreal injection of 0.1 ml bevacizumab: comparison between 27-gauge and 30-gauge needleKatrin Lorenz, Isabella Zwiener, Alireza Mirshahi
BMC Ophthalmology|December 24, 2013
Risk factors of a reduced response to ranibizumab treatment for neovascular age-related macular degeneration--evaluation in a clinical settingChristina Korb, Isabella Zwiener, Katrin Lorenz, et al.
Advances in Therapy|May 7, 2020
Pooled Safety and Tolerability Analysis of Empagliflozin in Patients with Type 2 Diabetes MellitusOna Kinduryte Schorling, Douglas Clark, Isabella Zwiener, et al.
Cardiovascular Diabetology|October 14, 2020
Empagliflozin reduced long-term HbA1c variability and cardiovascular death: insights from the EMPA-REG OUTCOME trialAntonio Ceriello, Anne Pernille Ofstad, Isabella Zwiener, et al.
Acta Ophthalmologica|June 30, 2010
Intravitreal ranibizumab treatment of retinal angiomatous proliferationChristina A Kramann, Kilian Schöpfer, Katrin Lorenz, et al.
Journal of the American College of Cardiology|March 20, 2019
Influence of Microvascular Disease on Cardiovascular Events in Type 2 DiabetesSubodh Verma, Christoph Wanner, Isabella Zwiener, et al.
European Journal of Radiology|July 18, 2016
Differences of airway dimensions between patients with and without bronchiolitis obliterans syndrome after lung transplantation-Computer-assisted quantification of computed tomographyFelix Doellinger, Oliver Weinheimer, Isabella Zwiener, et al.
Pageof 6